APO RESEARCH · REPORT
Peptide Synthesis
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Product & engineering
Understand the product.
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Selected research
Market Outlook & Growth Opportunities
Global Peptide Synthesis Market Outlook and Growth Opportunities 2026
Market perspective
Peptides are synthesized by coupling the carboxyl of one amino acid to the amino of another amino acid molecule. Due to the possibility of unintended reactions, protecting s are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
Global Peptide Synthesis key players include Bachem, PolyPeptide, USV Peptides, Thermofischer, GL Biochem etc.
Europe is the largest market, with a share over 30%, followed by North America and Asia-Pacific, both have a share over 50% percent.
Read the full market overview
This report provides an overview of the global Peptide Synthesis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Peptide Synthesis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Peptide Synthesis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Peptide Synthesis market size, projected growth trends, production technologies, key applications, and end-use industries.
Peptide Synthesis Segment by Company
Bachem
PolyPeptide
USV Peptides
Thermofischer
GL Biochem
Hybio
Bio Basic
JPT
Genscript
Xinbang
ScinoPharm
21st Century Bio
CPC Scientific
LifeTein
AnaSpec
New England Peptide
Biomatik
Proimmune
Peptide Synthesis Segment by Type
CRO Peptides
CMO Peptides
Generic API Peptides
Peptide Synthesis Segment by Application
Commercial
Academic Research
Peptide Synthesis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Peptide Synthesis status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Peptide Synthesis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Peptide Synthesis significant trends, drivers, influence factors in global and regions.
6. To analyze Peptide Synthesis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peptide Synthesis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peptide Synthesis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peptide Synthesis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Peptide Synthesis market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Peptide Synthesis industry.
Chapter 3: Detailed analysis of Peptide Synthesis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Peptide Synthesis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Peptide Synthesis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. Peptide Synthesis Industry Trends
Table 2. Peptide Synthesis Industry Drivers
Table 3. Peptide Synthesis Industry Opportunities and Challenges
Table 4. Peptide Synthesis Industry Restraints
Table 5. Global Peptide Synthesis Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global Peptide Synthesis Revenue Share by Company (2021-2026)
Table 7. Global Peptide Synthesis Sales Volume by Company (Kg) & (2021-2026)
Table 8. Global Peptide Synthesis Sales Volume Share by Company (2021-2026)
Table 9. Global Peptide Synthesis Average Price (USD/g) of Company (2021-2026)
Table 10. Global Peptide Synthesis Company Ranking, (2024-2026) & (USD Million)
Table 11. Global Peptide Synthesis Key Company Manufacturing Base & Headquarters
Table 12. Global Peptide Synthesis Company, Product Type & Application
Table 13. Global Peptide Synthesis Company Establishment Date
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Peptide Synthesis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Significant Companies of CRO Peptides
Table 18. Significant Companies of CMO Peptides
Table 19. Significant Companies of Generic API Peptides
Table 20. Global Peptide Synthesis Sales Volume by Type 2021 VS 2025 VS 2032 (Kg)
Table 21. Global Peptide Synthesis Sales Volume by Type (2021-2026) & (Kg)
Table 22. Global Peptide Synthesis Sales Volume by Type (2027-2032) & (Kg)
Table 23. Global Peptide Synthesis Sales Volume Share by Type (2021-2026)
Table 24. Global Peptide Synthesis Sales Volume Share by Type (2027-2032)
Table 25. Global Peptide Synthesis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 26. Global Peptide Synthesis Sales Value by Type (2021-2026) & (US$ Million)
Table 27. Global Peptide Synthesis Sales Value by Type (2027-2032) & (US$ Million)
Table 28. Global Peptide Synthesis Sales Value Share by Type (2021-2026)
Table 29. Global Peptide Synthesis Sales Value Share by Type (2027-2032)
Table 30. Significant Companies of Commercial
Table 31. Significant Companies of Academic Research
Table 32. Global Peptide Synthesis Sales Volume by Application 2021 VS 2025 VS 2032 (Kg)
Table 33. Global Peptide Synthesis Sales Volume by Application (2021-2026) & (Kg)
Table 34. Global Peptide Synthesis Sales Volume by Application (2027-2032) & (Kg)
Table 35. Global Peptide Synthesis Sales Volume Share by Application (2021-2026)
Table 36. Global Peptide Synthesis Sales Volume Share by Application (2027-2032)
Table 37. Global Peptide Synthesis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 38. Global Peptide Synthesis Sales Value by Application (2021-2026) & (US$ Million)
Table 39. Global Peptide Synthesis Sales Value by Application (2027-2032) & (US$ Million)
Table 40. Global Peptide Synthesis Sales Value Share by Application (2021-2026)
Table 41. Global Peptide Synthesis Sales Value Share by Application (2027-2032)
Table 42. Global Peptide Synthesis Sales by Region: 2021 VS 2025 VS 2032 (Kg)
Table 43. Global Peptide Synthesis Sales by Region (2021-2026) & (Kg)
Table 44. Global Peptide Synthesis Sales Market Share by Region (2021-2026)
Table 45. Global Peptide Synthesis Sales by Region (2027-2032) & (Kg)
Table 46. Global Peptide Synthesis Sales Market Share by Region (2027-2032)
Table 47. Global Peptide Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 48. Global Peptide Synthesis Sales Value by Region (2021-2026) & (US$ Million)
Table 49. Global Peptide Synthesis Sales Value Share by Region (2021-2026)
Table 50. Global Peptide Synthesis Sales Value by Region (2027-2032) & (US$ Million)
Table 51. Global Peptide Synthesis Sales Value Share by Region (2027-2032)
Table 52. Global Peptide Synthesis Market Average Price (USD/g) by Region (2021-2026)
Table 53. Global Peptide Synthesis Market Average Price (USD/g) by Region (2027-2032)
Table 54. Global Peptide Synthesis Sales by Country: 2021 VS 2025 VS 2032 (Kg)
Table 55. Global Peptide Synthesis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 56. Global Peptide Synthesis Sales by Country (2021-2026) & (Kg)
Table 57. Global Peptide Synthesis Sales Market Share by Country (2021-2026)
Table 58. Global Peptide Synthesis Sales by Country (2027-2032) & (Kg)
Table 59. Global Peptide Synthesis Sales Market Share by Country (2027-2032)
Table 60. Global Peptide Synthesis Sales Value by Country (2021-2026) & (US$ Million)
Table 61. Global Peptide Synthesis Sales Value Market Share by Country (2021-2026)
Table 62. Global Peptide Synthesis Sales Value by Country (2027-2032) & (US$ Million)
Table 63. Global Peptide Synthesis Sales Value Market Share by Country (2027-2032)
Table 64. Bachem Company Information
Table 65. Bachem Business Overview
Table 66. Bachem Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 67. Bachem Peptide Synthesis Product Portfolio
Table 68. Bachem Recent Development
Table 69. PolyPeptide Company Information
Table 70. PolyPeptide Business Overview
Table 71. PolyPeptide Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 72. PolyPeptide Peptide Synthesis Product Portfolio
Table 73. PolyPeptide Recent Development
Table 74. USV Peptides Company Information
Table 75. USV Peptides Business Overview
Table 76. USV Peptides Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 77. USV Peptides Peptide Synthesis Product Portfolio
Table 78. USV Peptides Recent Development
Table 79. Thermofischer Company Information
Table 80. Thermofischer Business Overview
Table 81. Thermofischer Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 82. Thermofischer Peptide Synthesis Product Portfolio
Table 83. Thermofischer Recent Development
Table 84. GL Biochem Company Information
Table 85. GL Biochem Business Overview
Table 86. GL Biochem Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 87. GL Biochem Peptide Synthesis Product Portfolio
Table 88. GL Biochem Recent Development
Table 89. Hybio Company Information
Table 90. Hybio Business Overview
Table 91. Hybio Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 92. Hybio Peptide Synthesis Product Portfolio
Table 93. Hybio Recent Development
Table 94. Bio Basic Company Information
Table 95. Bio Basic Business Overview
Table 96. Bio Basic Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 97. Bio Basic Peptide Synthesis Product Portfolio
Table 98. Bio Basic Recent Development
Table 99. JPT Company Information
Table 100. JPT Business Overview
Table 101. JPT Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 102. JPT Peptide Synthesis Product Portfolio
Table 103. JPT Recent Development
Table 104. Genscript Company Information
Table 105. Genscript Business Overview
Table 106. Genscript Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 107. Genscript Peptide Synthesis Product Portfolio
Table 108. Genscript Recent Development
Table 109. Xinbang Company Information
Table 110. Xinbang Business Overview
Table 111. Xinbang Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 112. Xinbang Peptide Synthesis Product Portfolio
Table 113. Xinbang Recent Development
Table 114. ScinoPharm Company Information
Table 115. ScinoPharm Business Overview
Table 116. ScinoPharm Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 117. ScinoPharm Peptide Synthesis Product Portfolio
Table 118. ScinoPharm Recent Development
Table 119. 21st Century Bio Company Information
Table 120. 21st Century Bio Business Overview
Table 121. 21st Century Bio Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 122. 21st Century Bio Peptide Synthesis Product Portfolio
Table 123. 21st Century Bio Recent Development
Table 124. CPC Scientific Company Information
Table 125. CPC Scientific Business Overview
Table 126. CPC Scientific Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 127. CPC Scientific Peptide Synthesis Product Portfolio
Table 128. CPC Scientific Recent Development
Table 129. LifeTein Company Information
Table 130. LifeTein Business Overview
Table 131. LifeTein Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 132. LifeTein Peptide Synthesis Product Portfolio
Table 133. LifeTein Recent Development
Table 134. AnaSpec Company Information
Table 135. AnaSpec Business Overview
Table 136. AnaSpec Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 137. AnaSpec Peptide Synthesis Product Portfolio
Table 138. AnaSpec Recent Development
Table 139. New England Peptide Company Information
Table 140. New England Peptide Business Overview
Table 141. New England Peptide Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 142. New England Peptide Peptide Synthesis Product Portfolio
Table 143. New England Peptide Recent Development
Table 144. Biomatik Company Information
Table 145. Biomatik Business Overview
Table 146. Biomatik Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 147. Biomatik Peptide Synthesis Product Portfolio
Table 148. Biomatik Recent Development
Table 149. Proimmune Company Information
Table 150. Proimmune Business Overview
Table 151. Proimmune Peptide Synthesis Sales (Kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026)
Table 152. Proimmune Peptide Synthesis Product Portfolio
Table 153. Proimmune Recent Development
Table 154. Key Raw Materials
Table 155. Raw Materials Key Suppliers
Table 156. Peptide Synthesis Distributors List
Table 157. Peptide Synthesis Customers List
Table 158. Research Programs/Design for This Report
Table 159. Authors List of This Report
Table 160. Secondary Sources
Table 161. Primary Sources
List of Figures
Figure 1. Peptide Synthesis Product Image
Figure 2. Global Peptide Synthesis Sales Value (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 4. Global Peptide Synthesis Sales (2021-2032) & (Kg)
Figure 5. Global Peptide Synthesis Sales Average Price (USD/g) & (2021-2032)
Figure 6. Global Peptide Synthesis Company Revenue Ranking in 2025 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 9. CRO Peptides Image
Figure 10. CMO Peptides Image
Figure 11. Generic API Peptides Image
Figure 12. Global Peptide Synthesis Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg)
Figure 13. Global Peptide Synthesis Sales Volume Share 2021 VS 2025 VS 2032
Figure 14. Global Peptide Synthesis Sales Volume Share by Type (2021-2032)
Figure 15. Global Peptide Synthesis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global Peptide Synthesis Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global Peptide Synthesis Sales Value Share by Type (2021-2032)
Figure 18. Commercial Image
Figure 19. Academic Research Image
Figure 20. Global Peptide Synthesis Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg)
Figure 21. Global Peptide Synthesis Sales Volume Share 2021 VS 2025 VS 2032
Figure 22. Global Peptide Synthesis Sales Volume Share by Application (2021-2032)
Figure 23. Global Peptide Synthesis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 24. Global Peptide Synthesis Sales Value Share 2021 VS 2025 VS 2032
Figure 25. Global Peptide Synthesis Sales Value Share by Application (2021-2032)
Figure 26. Global Peptide Synthesis Sales by Region: 2021 VS 2025 VS 2032 (Kg)
Figure 27. Global Peptide Synthesis Sales Market Share by Region: 2021 VS 2025 VS 2032
Figure 28. Global Peptide Synthesis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 29. Global Peptide Synthesis Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 30. North America Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 31. North America Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 32. Europe Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 33. Europe Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 34. Asia-Pacific Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 35. Asia-Pacific Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 36. South America Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 37. South America Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 38. Middle East & Africa Peptide Synthesis Sales Value (2021-2032) & (US$ Million)
Figure 39. Middle East & Africa Peptide Synthesis Sales Value Share by Country (%), 2025 VS 2032
Figure 40. USA Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 41. USA Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 42. USA Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 43. Canada Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 44. Canada Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 45. Canada Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 46. Mexico Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 47. Mexico Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 48. Mexico Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 49. Germany Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 50. Germany Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 51. Germany Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 52. France Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 53. France Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 54. France Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 55. U.K. Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 56. U.K. Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 57. U.K. Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 58. Italy Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 59. Italy Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 60. Italy Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 61. Spain Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 62. Spain Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 63. Spain Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 64. Russia Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 65. Russia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 66. Russia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 67. Netherlands Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 68. Netherlands Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 69. Netherlands Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 70. Nordic Countries Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 71. Nordic Countries Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 72. Nordic Countries Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 73. China Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 74. China Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 75. China Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 76. Japan Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 77. Japan Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 78. Japan Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 79. South Korea Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 80. South Korea Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 81. South Korea Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 82. India Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 83. India Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 84. India Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 85. Australia Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 86. Australia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 87. Australia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 88. Southeast Asia Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 89. Southeast Asia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 90. Southeast Asia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 91. Brazil Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 92. Brazil Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 93. Brazil Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 94. Argentina Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 95. Argentina Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 96. Argentina Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 97. Chile Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 98. Chile Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 99. Chile Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 100. Colombia Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 101. Colombia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 102. Colombia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 103. Peru Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 104. Peru Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 105. Peru Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 106. Saudi Arabia Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 107. Saudi Arabia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 108. Saudi Arabia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 109. Israel Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 110. Israel Arabia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 111. Israel Arabia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 112. UAE Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 113. UAE Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 114. UAE Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 115. Turkey Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 116. Turkey Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 117. Turkey Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 118. Iran Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 119. Iran Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 120. Iran Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 121. Egypt Peptide Synthesis Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 122. Egypt Peptide Synthesis Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 123. Egypt Peptide Synthesis Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 124. Peptide Synthesis Value Chain
Figure 125. Manufacturing Cost Structure
Figure 126. Peptide Synthesis Sales Mode & Process
Figure 127. Direct Comparison with Distribution Share
Figure 128. Distributors Profiles
Figure 129. Years Considered
Figure 130. Research Process
Figure 131. Key Executives Interviewed
Scope & coverage.
Types
- CRO Peptides
- CMO Peptides
- Generic API Peptides
Applications
- Commercial
- Academic Research
Companies covered
- Bachem
- PolyPeptide
- USV Peptides
- Thermofischer
- GL Biochem
- Hybio
- Bio Basic
- JPT
- Genscript
- Xinbang
- ScinoPharm
- 21st Century Bio
- CPC Scientific
- LifeTein
- AnaSpec
- New England Peptide
- Biomatik
- Proimmune
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Peptide Synthesis Sales Value (2021-2032)
- 1.2.2 Global Peptide Synthesis Sales Volume (2021-2032)
- 1.2.3 Global Peptide Synthesis Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Peptide Synthesis Market Dynamics
- 2.1 Peptide Synthesis Industry Trends
- 2.2 Peptide Synthesis Industry Drivers
- 2.3 Peptide Synthesis Industry Opportunities and Challenges
- 2.4 Peptide Synthesis Industry Restraints
3 Peptide Synthesis Market by Company
- 3.1 Global Peptide Synthesis Company Revenue Ranking in 2025
- 3.2 Global Peptide Synthesis Revenue by Company (2021-2026)
- 3.3 Global Peptide Synthesis Sales Volume by Company (2021-2026)
- 3.4 Global Peptide Synthesis Average Price by Company (2021-2026)
- 3.5 Global Peptide Synthesis Company Ranking (2024-2026)
- 3.6 Global Peptide Synthesis Company Manufacturing Base and Headquarters
- 3.7 Global Peptide Synthesis Company Product Type and Application
- 3.8 Global Peptide Synthesis Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Peptide Synthesis Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Peptide Synthesis Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Peptide Synthesis Market by Type
- 4.1 Peptide Synthesis Type Introduction
- 4.1.1 CRO Peptides
- 4.1.2 CMO Peptides
- 4.1.3 Generic API Peptides
- 4.2 Global Peptide Synthesis Sales Volume by Type
- 4.2.1 Global Peptide Synthesis Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Peptide Synthesis Sales Volume by Type (2021-2032)
- 4.2.3 Global Peptide Synthesis Sales Volume Share by Type (2021-2032)
- 4.3 Global Peptide Synthesis Sales Value by Type
- 4.3.1 Global Peptide Synthesis Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Peptide Synthesis Sales Value by Type (2021-2032)
- 4.3.3 Global Peptide Synthesis Sales Value Share by Type (2021-2032)
5 Peptide Synthesis Market by Application
- 5.1 Peptide Synthesis Application Introduction
- 5.1.1 Commercial
- 5.1.2 Academic Research
- 5.2 Global Peptide Synthesis Sales Volume by Application
- 5.2.1 Global Peptide Synthesis Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Peptide Synthesis Sales Volume by Application (2021-2032)
- 5.2.3 Global Peptide Synthesis Sales Volume Share by Application (2021-2032)
- 5.3 Global Peptide Synthesis Sales Value by Application
- 5.3.1 Global Peptide Synthesis Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Peptide Synthesis Sales Value by Application (2021-2032)
- 5.3.3 Global Peptide Synthesis Sales Value Share by Application (2021-2032)
6 Peptide Synthesis Regional Sales and Value Analysis
- 6.1 Global Peptide Synthesis Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Peptide Synthesis Sales by Region (2021-2032)
- 6.2.1 Global Peptide Synthesis Sales by Region: 2021-2026
- 6.2.2 Global Peptide Synthesis Sales by Region (2027-2032)
- 6.3 Global Peptide Synthesis Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Peptide Synthesis Sales Value by Region (2021-2032)
- 6.4.1 Global Peptide Synthesis Sales Value by Region: 2021-2026
- 6.4.2 Global Peptide Synthesis Sales Value by Region (2027-2032)
- 6.5 Global Peptide Synthesis Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Peptide Synthesis Sales Value (2021-2032)
- 6.6.2 North America Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Peptide Synthesis Sales Value (2021-2032)
- 6.7.2 Europe Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Peptide Synthesis Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Peptide Synthesis Sales Value (2021-2032)
- 6.9.2 South America Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Peptide Synthesis Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Peptide Synthesis Sales Value Share by Country, 2025 VS 2032
7 Peptide Synthesis Country-level Sales and Value Analysis
- 7.1 Global Peptide Synthesis Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Peptide Synthesis Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Peptide Synthesis Sales by Country (2021-2032)
- 7.3.1 Global Peptide Synthesis Sales by Country (2021-2026)
- 7.3.2 Global Peptide Synthesis Sales by Country (2027-2032)
- 7.4 Global Peptide Synthesis Sales Value by Country (2021-2032)
- 7.4.1 Global Peptide Synthesis Sales Value by Country (2021-2026)
- 7.4.2 Global Peptide Synthesis Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.9.2 France Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.16.2 China Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.19.2 India Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Peptide Synthesis Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Peptide Synthesis Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Peptide Synthesis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Bachem
- 8.1.1 Bachem Company Information
- 8.1.2 Bachem Business Overview
- 8.1.3 Bachem Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Bachem Peptide Synthesis Product Portfolio
- 8.1.5 Bachem Recent Developments
- 8.2 PolyPeptide
- 8.2.1 PolyPeptide Company Information
- 8.2.2 PolyPeptide Business Overview
- 8.2.3 PolyPeptide Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.2.4 PolyPeptide Peptide Synthesis Product Portfolio
- 8.2.5 PolyPeptide Recent Developments
- 8.3 USV Peptides
- 8.3.1 USV Peptides Company Information
- 8.3.2 USV Peptides Business Overview
- 8.3.3 USV Peptides Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.3.4 USV Peptides Peptide Synthesis Product Portfolio
- 8.3.5 USV Peptides Recent Developments
- 8.4 Thermofischer
- 8.4.1 Thermofischer Company Information
- 8.4.2 Thermofischer Business Overview
- 8.4.3 Thermofischer Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Thermofischer Peptide Synthesis Product Portfolio
- 8.4.5 Thermofischer Recent Developments
- 8.5 GL Biochem
- 8.5.1 GL Biochem Company Information
- 8.5.2 GL Biochem Business Overview
- 8.5.3 GL Biochem Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.5.4 GL Biochem Peptide Synthesis Product Portfolio
- 8.5.5 GL Biochem Recent Developments
- 8.6 Hybio
- 8.6.1 Hybio Company Information
- 8.6.2 Hybio Business Overview
- 8.6.3 Hybio Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Hybio Peptide Synthesis Product Portfolio
- 8.6.5 Hybio Recent Developments
- 8.7 Bio Basic
- 8.7.1 Bio Basic Company Information
- 8.7.2 Bio Basic Business Overview
- 8.7.3 Bio Basic Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Bio Basic Peptide Synthesis Product Portfolio
- 8.7.5 Bio Basic Recent Developments
- 8.8 JPT
- 8.8.1 JPT Company Information
- 8.8.2 JPT Business Overview
- 8.8.3 JPT Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.8.4 JPT Peptide Synthesis Product Portfolio
- 8.8.5 JPT Recent Developments
- 8.9 Genscript
- 8.9.1 Genscript Company Information
- 8.9.2 Genscript Business Overview
- 8.9.3 Genscript Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Genscript Peptide Synthesis Product Portfolio
- 8.9.5 Genscript Recent Developments
- 8.10 Xinbang
- 8.10.1 Xinbang Company Information
- 8.10.2 Xinbang Business Overview
- 8.10.3 Xinbang Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Xinbang Peptide Synthesis Product Portfolio
- 8.10.5 Xinbang Recent Developments
- 8.11 ScinoPharm
- 8.11.1 ScinoPharm Company Information
- 8.11.2 ScinoPharm Business Overview
- 8.11.3 ScinoPharm Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.11.4 ScinoPharm Peptide Synthesis Product Portfolio
- 8.11.5 ScinoPharm Recent Developments
- 8.12 21st Century Bio
- 8.12.1 21st Century Bio Company Information
- 8.12.2 21st Century Bio Business Overview
- 8.12.3 21st Century Bio Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.12.4 21st Century Bio Peptide Synthesis Product Portfolio
- 8.12.5 21st Century Bio Recent Developments
- 8.13 CPC Scientific
- 8.13.1 CPC Scientific Company Information
- 8.13.2 CPC Scientific Business Overview
- 8.13.3 CPC Scientific Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.13.4 CPC Scientific Peptide Synthesis Product Portfolio
- 8.13.5 CPC Scientific Recent Developments
- 8.14 LifeTein
- 8.14.1 LifeTein Company Information
- 8.14.2 LifeTein Business Overview
- 8.14.3 LifeTein Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.14.4 LifeTein Peptide Synthesis Product Portfolio
- 8.14.5 LifeTein Recent Developments
- 8.15 AnaSpec
- 8.15.1 AnaSpec Company Information
- 8.15.2 AnaSpec Business Overview
- 8.15.3 AnaSpec Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.15.4 AnaSpec Peptide Synthesis Product Portfolio
- 8.15.5 AnaSpec Recent Developments
- 8.16 New England Peptide
- 8.16.1 New England Peptide Company Information
- 8.16.2 New England Peptide Business Overview
- 8.16.3 New England Peptide Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.16.4 New England Peptide Peptide Synthesis Product Portfolio
- 8.16.5 New England Peptide Recent Developments
- 8.17 Biomatik
- 8.17.1 Biomatik Company Information
- 8.17.2 Biomatik Business Overview
- 8.17.3 Biomatik Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Biomatik Peptide Synthesis Product Portfolio
- 8.17.5 Biomatik Recent Developments
- 8.18 Proimmune
- 8.18.1 Proimmune Company Information
- 8.18.2 Proimmune Business Overview
- 8.18.3 Proimmune Peptide Synthesis Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Proimmune Peptide Synthesis Product Portfolio
- 8.18.5 Proimmune Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Peptide Synthesis Value Chain Analysis
- 9.1.1 Peptide Synthesis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Peptide Synthesis Sales Mode & Process
- 9.2 Peptide Synthesis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Peptide Synthesis Distributors
- 9.2.3 Peptide Synthesis Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst